|
NPPA fixed ceiling prices of 890 formulations and retail price of 2023 new drugs: Minister
|
|
Our Bureau, New Delhi
July 23 , 2022
|
|
|
The National Pharmaceutical Pricing Authority (NPPA) has so far fixed ceiling prices of 890 scheduled formulations and retail price of around 2,023 new drugs, among others, said minister of state for chemicals and fertilisers, Bhagwanth Khuba.
In a written reply in Lok Sabha, he said that the NPPA has fixed the ceiling prices of 890 scheduled formulations across various therapeutic categories under the National List of Essential Medicines (NLEM) 2015 and retail prices of 2,023 new drugs under the Drug (Prices Control) Order, 2013.
Maximum retail price of 106 non-scheduled drug formulations were capped, including that for 22 diabetic and 84 cardiovascular drugs. Ceiling prices of orthopaedic knee implants were fixed under Para 19 of DPCO, 2013.
Trade Margin of non-scheduled formulations of 42 select anti-cancer medicines were capped under ‘Trade Margin Rationalization’ approach as a pilot for proof of concept.
The NPPA has also regulated the price of oxygen concentrators, pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer and glucometer under ‘Trade Margin Rationalisation’ Approach.
The National List of Essential Medicines (NLEM) notified by the Ministry of Health & Family Welfare consists of essential medicines falling under various therapeutic categories. These medicines are incorporated in the First Schedule of the DPCO, 2013 and their ceiling prices are fixed by NPPA as per provisions of DPCO, 2013, said the Minister.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|